A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.

An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody ...

Antibodies are proteins that circulate in the blood and protect against foreign antigenic substances such as bacteria, viruses, fungi, parasites, chemicals, or toxins. They are Y-shaped structures ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

In the United States, envenomation (the injection of venom) usually happens during an encounter with a snake, spider, or insect. Antivenom (often spelled “antivenin”) is an antibody product that can ...

Stefano Gullà, chief scientific officer at Kling Biotherapeutics, discusses how new approaches in antibody research technology could halt this and other outbreaks. Mpox is spreading rapidly in ...

Researchers at the University of Texas at Austin claim they may have cracked the Covid code by discovering a new antibody that could be used to create a vaccine that could combat all variants of the ...

In a groundbreaking discovery, researchers at The University of Texas at Austin have identified an antibody capable of ...

‘Approximately 20% of women experiencing recurrent #pregnancy loss test positive for an antibody that can be dangerous to their bodies. #heparin #treatment #medindia’ Tanimura points out ...

Weizmann Institute of Science researchers present a new algorithm to greatly speed up the process of engineering therapeutic proteins to protect against diseases. Researchers at the Weizmann ...

Researchers at the University of Texas at Austin say they have discovered an antibody that could effectively fight against all variants of COVID-19, along with other related viruses. Scientists at ...

Agnostic B cell selection approach identifies antibodies against K. pneumoniae that synergistically drive complement activation. Nature Communications , 2024; 15 (1) DOI: 10.1038/s41467-024-52372 ...